Valeo Pharma Inc. (OTCMKTS:VPHIF) Stock Soars As Company Signs Agreement with Veru Inc. for Sabizabulin

September 15, 2022

Valeo Pharma Inc. (OTCMKTS:VPHIF) announced on September 14, 2022, about signing a Commercial Services Agreement with Veru Inc. for sabizabulin to treat COVID-19 in Canada. Sabizabulin is a novel dual antiviral and anti-inflammatory agent – it is being targeted for treating hospitalized moderate-severe COVID-19 patients at high risk for acute respiratory distress syndrome (ARDS) and death. Trading Data On Wednesday, VPHIF stock jumped 96.33% to $0.4490 with more than 2.90K…

Read More >>